Immunization with a mixture of HIV Env DNA and VLP vaccines augments induction of CD8 T cell responses

Journal of Biomedicine and Biotechnology

Volumn 2010, Issue , 2010, Pages

  Ye, Ling ^a   Wen, Zhiyuan ^a,b   Dong, Ke ^a,c   Pan, Lei ^a,c   Bu, Zhigao ^b   Compans, Richard W ^a   Zhang, Huizhong ^c   Yang, Chinglai ^a  

^a EMORY UNIVERSITY   (United States)

^b INSTITUTE OF PLANT PROTECTION   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS LIKE PARTICLE VACCINE; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; MOUSE; NONHUMAN;

EID: 77953483341     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2010/497219     Document Type: Article

References (43)

1. Cohen J., Clinical research. A setback and an advance on the AIDS vaccine front Science 2003 300 5616 28 29
2. Germain R. N., Margulies D. H., The biochemistry and cell biology and antigen processing and presentation Annual Review of Immunology 1993 11 403 450
3. Pitisuttithum P., Gilbert P., Gurwith M., Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand Journal of Infectious Diseases 2006 194 12 1661 1671
4. Amara R. R., Villinger F., Altman J. D., Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine Science 2001 292 5514 69 74
5. Barouch D. H., Vaccine-elicited immune responses prevent clinical AIDS in SHIV(89.6P)-infected rhesus monkeys Immunology Letters 2001 79 1-2 57 61
6. Rose N. F., Marx P. A., Luckay A., An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants Cell 2001 106 5 539 549
7. Shiver J. W., Fu T.-M., Chen L., Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity Nature 2002 415 6869 331 335
8. Miedema F., A brief history of HIV vaccine research: stepping back to the drawing board? AIDS 2008 22 14 1699 1703
9. Burton D. R., Desrosiers R. C., Doms R. W., HIV vaccine design and the neutralizing antibody problem Nature Immunology 2004 5 3 233 236
10. Letvin N. L., Walker B. D., Immunopathogenesis and immunotherapy in AIDS virus infections Nature Medicine 2003 9 7 861 866
11. McMichael A. J., Hanke T., HIV vaccines 19832003 Nature Medicine 2003 9 7 874 880
12. Nabel G. J., Challenges and opportunities for development of an AIDS vaccine Nature 2001 410 6831 1002 1007
13. Donnelly J. J., Ulmer J. B., Shiver J. W., Liu M. A., DNA vaccines Annual Review of Immunology 1997 15 617 648
14. Gurunathan S., Klinman D. M., Seder R. A., DNA vaccines: immunology, application, and optimization Annual Review of Immunology 2000 18 927 974
15. Shedlock D. J., Weiner D. B., DNA vaccination: antigen presentation and the induction of immunity Journal of Leukocyte Biology 2000 68 6 793 806
16. Dupuis M., Denis-Mize K., Woo C., Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice Journal of Immunology 2000 165 5 2850 2858
17. Noad R., Roy P., Virus-like particles as immunogens Trends in Microbiology 2003 11 9 438 444
18. Yang C., Ye L., Compans R. W., Protection against filovirus infection: virus-like particle vaccines Expert Review of Vaccines 2008 7 3 333 344
19. Yao Q., Bu Z., Vzorov A., Yang C., Compans R. W., Virus-like particle and DNA-based candidate AIDS vaccines Vaccine 2003 21 7-8 638 643
20. Bachmann M. F., Rohrer U. H., Kundig T. M., Burki K., Hengartner H., Zinkernagel R. M., The influence of antigen organization on B cell responsiveness Science 1993 262 5138 1448 1451
21. Bachmann M. F., Hengartner H., Zinkernagel R. M., T helper cell-independent neutralizing B cell response against vesicular stomatitis virus: role of antigen patterns in B cell induction? European Journal of Immunology 1995 25 12 3445 3451
22. Deml L., Kratochwil G., Osterrieder N., Knchel R R., Wolf H., Wagner R., Increased incorporation of chimeric human immunodeficiency virus type 1 gp120 proteins into Pr55(gag) virus-like particles by an Epstein-Barr virus gp220/350-derived transmembrane domain Virology 1997 235 1 10 25
23. Notka F., Stahl-Hennig C., Dittmer U., Wolf H., Wagner R., Accelerated clearance of SHIV in rhesus monkeys by virus-like particle vaccines is dependent on induction of neutralizing antibodies Vaccine 1999 18 3-4 291 301
24. Deml L., Speth C., Dierich M. P., Wolf H., Wagner R., Recombinant HIV-1 Pr55gag virus-like particles: potent stimulators of innate and acquired immune responses Molecular Immunology 2005 42 2 259 277
25. Doan L. X., Li M., Chen C., Yao Q., Virus-like particles as HIV-1 vaccines Reviews in Medical Virology 2005 15 2 75 88
26. Bu Z., Ye L., Vzorov A., Taylor D., Compans R. W., Yang C., Enhancement of immunogenicity of an HIV Env DNA vaccine by mutation of the Tyr-based endocytosis motif in the cytoplasmic domain Virology 2004 328 1 62 73
27. Yamshchikov G. V., Ritter G. D., Vey M., Compans R. W., Assembly of SIV virus-like particles containing envelope proteins using a baculovirus expression system Virology 1995 214 1 50 58
28. Yao Q., Kuhlmann F. M., Eller R., Compans R. W., Chen C., Production and characterization of simian-human immunodeficiency virus-like particles AIDS Research and Human Retroviruses 2000 16 3 227 236
29. Bu Z., Ye L., Skeen M. J., Ziegler H. K., Compans R. W., Yang C., Enhancement of immune responses to an HIV env DNA vaccine by a C-terminal segment of listeriolysin O AIDS Research and Human Retroviruses 2003 19 5 409 420
30. Ye L., Bu Z., Vzorov A., Taylor D., Compans R. W., Yang C., Surface stability and immunogenicity of the human immunodeficiency virus envelope glycoprotein: role of the cytoplasmic domain Journal of Virology 2004 78 24 13409 13419
31. Lutz M. B., Kukutsch N., Ogilvie A. L. J., An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow Journal of Immunological Methods 1999 223 1 77 92
32. Yao Q., Zhang R., Guo L., Li M., Chen C., Th cell-independent immune responses to chimeric hemagglutinin/simian human immunodeficiency virus-like particles vaccine Journal of Immunology 2004 173 3 1951 1958
33. Girard M. P., Osmanov S. K., Kieny M. P., A review of vaccine research and development: the human immunodeficiency virus (HIV) Vaccine 2006 24 19 4062 4081
34. Montefiori D. C., Safrit J. T., Lydy S. L., Induction of neutralizing antibodies and Gag-specific cellular immune responses to an R5 primary isolate of human immunodeficiency virus type 1 in rhesus macaques Journal of Virology 2001 75 13 5879 5890
35. Boyle J. S., Silva A., Brady J. L., Lew A. M., DNA immunization: induction of higher avidity antibody and effect of route on T cell cytotoxicity Proceedings of the National Academy of Sciences of the United States of America 1997 94 26 14626 14631
36. Drew D. R., Lightowlers M., Strugnell R. A., Humoral immune responses to DNA vaccines expressing secreted, membrane bound and non-secreted forms of the Taenia ovis 45W antigen Vaccine 2000 18 23 2522 2532
37. Mosmann T. R., Coffman R. L., TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties Annual Review of Immunology 1989 7 145 173
38. Milich D. R., Schodel F., Hughes J. L., Jones J. E., Peterson D. L., The hepatitis B virus core and e antigens elicit different Th cell subsets: antigen structure can affect Th cell phenotype Journal of Virology 1997 71 3 2192 2201
39. Zhang S., Cubas R., Li M., Chen C., Yao Q., Virus-like particle vaccine activates conventional B2 cells and promotes B cell differentiation to IgG2a producing plasma cells Molecular Immunology 2009 46 10 1988 2001
40. Romagnani S., Kaplan M. H., Grusby M. J., Understanding the role of Th1/Th2 cells in infection Trends in Microbiology 1996 4 12 470 473
41. Gregoriadis G., Bacon A., Caparros-Wanderley W., McCormack B., A role for liposomes in genetic vaccination Vaccine 2002 20 supplement 5 B1 B9
42. Da Silva D. M., Velders M. P., Nieland J. D., Schiller J. T., Nickoloff B. J., Kast W. M., Physical interaction of human papillomavirus virus-like particles with immune cells International Immunology 2001 13 5 633 641
43. Ruedl C., Storni T., Lechner F., Bachi T., Bachmann M. F., Cross-presentation of virus-like particles by skin-derived CD8- dendritic cells: a dispensable role for TAP European Journal of Immunology 2002 32 3 818 825